A method for rapidly synthesizing 3-bromo-2-fluorobenzaldehyde based on continuous flow reaction technology
By adopting continuous flow reaction technology and nitrogen equilibrium system in 3-bromo-2-fluorobenzaldehyde synthesis, lithium hydrogen exchange and nucleophilic aldehyde synthesization reactions, the problems of high cost, poor safety and amplification effects in the existing technology are solved. , achieving efficient, safe and low-cost 3-bromo-2-fluorobenzaldehyde production, significantly improving yield and purity.
Patent Information
- Application Number
- CN202110569384.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-05-25
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2041-05-25
AI Technical Summary
The existing 3-bromo-2-fluorobenzaldehyde synthesis technology has problems such as high cost, poor safety and serious amplification effects. The traditional batch kettle reaction process is complex and not suitable for large-scale production.
Using continuous flow reaction technology, lithium hydrogen exchange and nucleophilic aldehyde synthesization reaction is realized through the pressure of nitrogen equilibrium system, and a two-step reaction is carried out using a multi-stage series-connected fully mixed reactor to generate 3-bromo-2-fluorobenzaldehyde and reduce metal lithium The risk and side reactions of reagents improve the control of reactions.
The rapid, efficient and safe production of 3-bromo-2-fluorobenzaldehyde is achieved, with a yield of more than 65% and a purity of more than 96%, which significantly improves the process efficiency, reduces costs, and avoids the amplification effect of the kettle-type reaction.
Smart Images

Figure FDA0005045619730000011 
Figure HDA0003082066330000011 
Figure 726010DEST_PATH_IMAGE002
Abstract
Description
Technical Field
[0001] The invention relates to a method for synthesizing 3-bromo-2-fluorobenzaldehyde, in particular to a method for rapidly preparing 3-bromo-2-fluorobenzaldehyde by utilizing a continuous flow reaction technology. Background Art
[0002] 3-Bromo-2-fluorobenzaldehyde, molecular formula: C7H4BrFO, is an important organic intermediate widely used in pharmaceutical molecules, fine chemicals, functional materials and other fields. It and its downstream products such as 3-bromo-2-fluorobenzophenone, (3-bromo-2-fluorophenyl)methanol, 7-bromo-1-benzothiophene-2-carboxylic acid, etc. have extremely high added value. The traditional preparation of 3-bromo-2-fluorobenzaldehyde is generally carried out in an intermittent reactor. The common synthetic routes are as follows:
[0003] Invention patent US2008114167A1 reports a method of using 3-bromo-2-fluorobenzoic acid as a raw material, reducing the raw acid to the corresponding 3-bromo-2-fluorobenzyl alcohol with lithium aluminum tetrahydride (LiAlH4), and then using pyridinium chlorochromate (PCC) as an oxidant to oxidize 3-bromo-2-fluorobenzyl alcohol to the target product in a tank reactor. However, this method has a complicated process route, a long reaction time, explosive decomposition of LiAlH4 upon contact with water, and toxicity of PCC. If kilogram-level production is to be scaled up, there are many limiting factors. Invention patent WO2015052226A1 directly uses 3-bromo-2-fluorobenzyl alcohol as a raw material and manganese dioxide as an oxidant to oxidize the raw material to 3-bromo-2-fluorobenzaldehyde. The above two methods have high preparation costs and low economic benefits.
[0004] The synthetic route used in the invention patent WO2013092756A1 is similar to that of the present invention, using relatively cheap o-fluorobromobenzene as the raw material, n-butyl lithium and 2,2,6,6-tetramethylpiperidine prepared tetramethylpiperidinium lithium as the hydrogen extraction reagent, N,N-dimethylformamide as the aldehyde reagent, and reacting at -78 °C for 1.5h. Since both steps of the reaction are highly exothermic, the materials need to be added dropwise to prevent accidents caused by temperature runaway. In addition, if production is scaled up, on the one hand, the time consumption will be seriously increased; on the other hand, since the autoclave reactor is a fully mixed reactor, severe back mixing will lead to a sharp increase in side reactions, and the scale-up effect is obvious.
[0005] In view of the problems of high cost and poor safety in the existing 3-bromo-2-fluorobenzaldehyde synthesis technology, the present invention couples a low-cost synthesis route with a continuous flow reaction technology to make the synthesis process continuous, simple and safe, and can curb the amplification effect problem to the greatest extent, thereby improving the product process efficiency. Summary of the invention
[0006] In order to overcome the shortcomings of the prior art, the present invention provides a method for rapidly synthesizing 3-bromo-2-fluorobenzaldehyde by using a continuous flow reaction technology, thereby being able to rapidly, efficiently and safely synthesize 3-bromo-2-fluorobenzaldehyde.
[0007] The present invention is realized by the following technical scheme: The present invention discloses a method for rapidly synthesizing 3-bromo-2-fluorobenzaldehyde based on continuous flow reaction technology. The process relies on nitrogen to balance the system pressure to achieve continuity. The synthesis method includes two steps of lithium hydrogen exchange and nucleophilic formaldehyde reaction. The specific steps are as follows:
[0008] (1) Lithium-hydrogen exchange reaction:
[0009] Before the reaction starts, the nitrogen valve is opened to balance the system pressure, and the o-fluorobromobenzene solution and the organic lithium reagent solution are pumped into the lithium hydrogen exchange continuous reactor in a certain equivalent ratio, and the lithium hydrogen exchange is carried out at a certain temperature for a certain time to generate a 3-bromo-2-fluorophenyl lithium intermediate.
[0010] (2) Nucleophilic aldehyde reaction:
[0011] The 3-bromo-2-fluorophenyl lithium intermediate solution obtained in step (1) is introduced into a continuous reactor for aldehyde formation, and a certain equivalent ratio of N,N-dimethylformamide solution is pumped into the continuous reactor for aldehyde formation, and the reaction is carried out at a certain temperature for a certain time to generate a 3-bromo-2-fluorobenzaldehyde product.
[0012] The reaction route is as follows:
[0013]
[0014] The solvent used in the o-fluorobromobenzene solution in step (1) is at least one of tetrahydrofuran, toluene and anhydrous ether; the organic lithium reagent is at least one of methyl lithium, butyl lithium, n-hexyl lithium, sec-butyl lithium, phenyl lithium, lithium tetramethyl piperidine, lithium diisopropylamide (LDA) and lithium hexamethyldisilazide (LiHMDS), preferably LDA; the solvent used in the organic lithium reagent solution is at least one of n-hexane, cyclohexane, n-heptane and tetrahydrofuran.
[0015] In step (1), the equivalent ratio of o-fluorobromobenzene to LDA is 1:1 to 1:2, and the reaction temperature is -40 to -78°C.
[0016] The lithium hydrogen exchange continuous reactor in step (1) is a multi-stage series fully mixed reactor, and the number of series stages is 1 to 5, preferably 1 to 3.
[0017] The reaction time in step (1) is 1 to 30 minutes, preferably 5 to 20 minutes, in each stage of the fully mixed reactor connected in series.
[0018] The solvent used in the N,N-dimethylformamide solution in step (2) is at least one of tetrahydrofuran, toluene and anhydrous ether.
[0019] In step (2), the equivalent ratio of o-fluorobromobenzene to N,N-dimethylformamide is 1:1 to 1:2, and the reaction temperature is -40 to -78°C.
[0020] The formaldehyde continuous reactor in step (2) is a multi-stage series fully mixed reactor, and the number of series stages is 1 to 3, preferably 1 to 2.
[0021] The reaction time in step (2) is 1 to 30 minutes, preferably 5 to 20 minutes, in each stage of the fully mixed reactor connected in series.
[0022] The beneficial effects of the present invention are as follows: the innovation of the present invention lies in coupling a low-cost synthesis route with a continuous flow reaction technology, solving the amplification effect of a batch reaction, reducing the risk factor of a metal lithium reagent reaction operation, and providing a safe, efficient, and low-cost process method for the production and synthesis of 3-bromo-2-fluorobenzaldehyde, so that the reaction can obtain a product with an ideal yield (>65%) and purity (>96%) under controllable continuous conditions, which is significantly better than the batch yield (20%) under the same amplification conditions, so that the process of the present invention is different from the existing batch process. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 The synthetic process flow chart of 3-bromo-2-fluorobenzaldehyde of the present invention is as follows:
[0024] In the figure: 1-o-fluorobromobenzene solution storage tank; 2-organic lithium reagent solution storage tank; 3-N,N-dimethylformamide solution storage tank; 4-first metering pump; 5-second metering pump; 6-third metering pump; 7-first flowmeter; 8-second flowmeter; 9-third flowmeter; 10-o-fluorobromobenzene feed precooling tube; 11-N,N-dimethylformamide feed precooling tube; 12-first stage lithium hydrogen exchange continuous reactor; 13-second stage lithium hydrogen exchange continuous reactor; 14-third stage lithium hydrogen exchange continuous reactor; 15-first stage formaldehyde continuous reactor (multi-stage series fully mixed reactor); 16-second stage formaldehyde continuous reactor; 17-product quenching collection tank; 18-nitrogen inlet; 19-thermocouple thermometer; 20-tail gas treatment module; 21-temperature control device. DETAILED DESCRIPTION
[0025] The present invention is described in detail below in conjunction with the accompanying drawings and specific embodiments.
[0026] Example 1: Figure 1As shown, a THF solution of o-fluorobromobenzene is loaded into a storage tank 1, and a THF solution of LDA is loaded into a storage tank 2, and the temperature control device 21 is set to a temperature of -80°C. The o-fluorobromobenzene THF solution and the LDA THF solution are respectively pumped into a first-stage lithium hydrogen exchange continuous reactor 12 by a first metering pump 4 and a second metering pump 5 for reaction for 8 minutes, and the reaction time is extended by 30 minutes through the second and third-stage lithium hydrogen exchange continuous reactors 13 and 14. The molar equivalent ratio of o-fluorobromobenzene to LDA is 1:1.5, and the reaction generates a 3-bromo-2-fluorophenyl lithium intermediate; the active intermediate is passed into a first-stage formaldehyde continuous reactor 15, and a THF solution of N,N-dimethylformamide is pumped into the reactor 15 for nucleophilic formaldehyde reaction, the molar equivalent ratio of o-fluorobromobenzene to N,N-dimethylformamide is 1:1.5, the residence time in the first-stage formaldehyde continuous reactor is 10 minutes, and the residence time is extended by 10 minutes through the second-stage formaldehyde continuous reactor 16. min reaction time, the product reaction solution was passed into the product quenching collection tank 17 containing 1 / 3 volume of quenching solution, the organic phase was diluted with acetonitrile and filtered, and then HPLC analysis showed that the conversion rate of 3-bromo-2-fluorobenzaldehyde in the reaction solution was 71.29%, 1 H-NMR (Instrument brand: Joel, Model: JNM-ECZ400S / L1 Parameter 400 MHz, Solvent d6-DMSO)δ 10.17 (s, 1H), 7.99 - 8.02 (m, 1H), 7.79 - 7.83 (m, 1H), 7.33 (t, J = 8.0 Hz, 1H).
[0027] Example 2: The specific preparation process is the same as that of Example 1. The temperature of the temperature control device 21 is set to -60°C. The organic phase of the reaction solution is diluted and filtered, and then HPLC analysis is performed to show that the conversion rate of 3-bromo-2-fluorobenzaldehyde in the reaction solution is 68.78%.
[0028] Example 3: The specific preparation process is the same as that of Example 1, except that the molar equivalent ratio of o-fluorobromobenzene and LDA is adjusted to 1:1.7. The organic phase of the reaction solution is diluted and filtered, and then HPLC analysis is performed, showing that the conversion rate of 3-bromo-2-fluorobenzaldehyde in the reaction solution is 70.84%.
[0029] Example 4: The specific preparation process is the same as that of Example 1, except that the molar equivalent ratio of o-fluorobromobenzene and N,N-dimethylformamide is adjusted to 1:1.8, and the organic phase of the reaction solution is diluted and filtered, and then HPLC analysis is performed, showing that the conversion rate of 3-bromo-2-fluorobenzaldehyde in the reaction solution is 70.12%.
[0030] Finally, it should be noted that the above content is only used to illustrate the technical solution of the present invention, rather than to limit the scope of protection of the present invention. Simple modifications or equivalent substitutions of the technical solution of the present invention by ordinary technicians in this field do not deviate from the essence and scope of the technical solution of the present invention.
Claims
1. A method for rapidly synthesizing 3-bromo-2-fluorobenzaldehyde based on continuous flow reaction technology, Features: The method relies on nitrogen to balance the system pressure, and uses a pump device to achieve continuous feeding and discharging. The synthesis method includes two steps of lithium hydrogen exchange and nucleophilic aldehyde formation. The specific steps are as follows: (1) Lithium-hydrogen exchange reaction: Before the reaction starts, the nitrogen valve is opened to balance the system pressure, and the o-fluorobromobenzene solution and the organic lithium reagent solution are pumped into the lithium hydrogen exchange continuous reactor in a certain equivalent ratio, and the lithium hydrogen exchange is carried out at a certain temperature for a certain time to generate 3-bromo-2-fluorophenyl lithium intermediate; (2) Nucleophilic aldehyde reaction: The active intermediate obtained in step (1) is introduced into a continuous reactor for hydroformylation, and a certain equivalent ratio of N,N-dimethylformamide solution is pumped into the continuous reactor for hydroformylation, and the reaction is carried out at a certain temperature for a certain time to generate a 3-bromo-2-fluorobenzaldehyde product; The reaction route is as follows: The solvent used in the o-fluorobromobenzene solution in step (1) is at least one of tetrahydrofuran, toluene and anhydrous ether; the organic lithium reagent is at least one of methyl lithium, butyl lithium, n-hexyl lithium, sec-butyl lithium, phenyl lithium, lithium tetramethyl piperidine, lithium diisopropylamide (LDA) and lithium hexamethyldisilazide (LiHMDS); the solvent used in the organic lithium reagent solution is at least one of n-hexane, cyclohexane, n-heptane and tetrahydrofuran; In step (1), the equivalent ratio of o-fluorobromobenzene to LDA is 1:1 to 1:2, and the reaction temperature is -40 to -78°C; The lithium hydrogen exchange continuous reactor in step (1) is a multi-stage series fully mixed reactor, and the number of series stages is 1 to 5; The reaction time in step (1) is 1 to 30 minutes in each stage of the fully mixed reactor in series; The solvent used in the N,N-dimethylformamide solution in step (2) is at least one of tetrahydrofuran, toluene and anhydrous ether; In step (2), the equivalent ratio of o-fluorobromobenzene to N,N-dimethylformamide is 1:1 to 1:2, and the reaction temperature is -40 to -78°C; The aldehyde formation continuous reactor in step (2) is a multi-stage series fully mixed reactor, and the number of series stages is 1 to 3; The reaction time in step (2) is 1 to 30 minutes in each stage of the fully mixed reactor connected in series.
Citation Information
Patent Citations
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners
US20080114167A1
Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
WO2013092756A1
Thiazolopyrimidinones as modulators of NMDA receptor activity
WO2015052226A1
Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application
CN104136030A
Method for producing 3-difluoromethoxy-5-fluorophenylboronic acid by continuous flow reactor
CN106478707A
